1. Home
  2. RUM vs AMPH Comparison

RUM vs AMPH Comparison

Compare RUM & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rumble Inc.

RUM

Rumble Inc.

HOLD

Current Price

$6.67

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$27.12

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUM
AMPH
Founded
2013
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.2B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
RUM
AMPH
Price
$6.67
$27.12
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$15.00
$31.00
AVG Volume (30 Days)
2.4M
380.2K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.27
Revenue
$103,782,153.00
$723,305,000.00
Revenue This Year
$7.04
$1.35
Revenue Next Year
$171.73
$5.10
P/E Ratio
N/A
$11.95
Revenue Growth
21.17
N/A
52 Week Low
$5.11
$20.39
52 Week High
$17.40
$39.01

Technical Indicators

Market Signals
Indicator
RUM
AMPH
Relative Strength Index (RSI) 46.88 55.26
Support Level $6.76 $26.26
Resistance Level $7.18 $27.44
Average True Range (ATR) 0.36 0.82
MACD -0.03 0.06
Stochastic Oscillator 24.03 83.33

Price Performance

Historical Comparison
RUM
AMPH

About RUM Rumble Inc.

Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: